QSAM Biosciences, Inc.
OTC:QSAM
7 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0.917 | 0.033 | 0.075 | 0.04 | 0.02 | 0 | 0.004 | 0.429 | 0.086 | 0.115 | 0.072 | 0.487 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 372,938 | 0 | 0 | 0.063 | 0.007 | 0.006 | 0.002 | 0.001 | 0.293 | 0.078 | 0.14 | 0.116 | 0.762 | 0 |
| Gross Profit
| 0 | 0 | 0 | -372,938 | 0.916 | 0.033 | 0.011 | 0.033 | 0.014 | -0.002 | 0.003 | 0.136 | 0.008 | -0.024 | -0.044 | -0.275 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 1 | 1 | 0.153 | 0.821 | 0.71 | 0 | 0.713 | 0.317 | 0.097 | -0.21 | -0.612 | -0.565 | 0 |
| Reseach & Development Expenses
| 1.16 | 1.022 | 0.647 | 0.362 | 0 | 0 | 0 | 0.353 | 1.424 | 0.013 | 0.009 | 0.295 | 0.434 | 0.5 | 0.432 | 0.844 | 0 |
| General & Administrative Expenses
| 0.002 | 4.439 | 10.394 | 0.962 | 2.079 | 1.611 | 1.337 | 1.728 | 1.975 | 4.524 | 0.045 | 1.555 | 1.976 | 0 | 0 | 2.431 | 0.075 |
| Selling & Marketing Expenses
| -1,780,810.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.251 | 0.34 | 0 | 0 | 0.01 | 0.02 |
| SG&A
| 2.783 | 4.439 | 10.394 | 0.962 | 2.079 | 1.611 | 1.337 | 1.728 | 1.975 | 4.524 | 0.045 | 1.806 | 2.316 | 4.043 | 2.166 | 2.441 | 0.095 |
| Other Expenses
| 0 | 0 | 0 | -3.17 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0.017 | 0 | 1.171 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 3.943 | 5.461 | 11.041 | 1.324 | 2.079 | 1.611 | 1.337 | 2.08 | 3.399 | 4.539 | 0.071 | 2.101 | 3.921 | 4.544 | 2.598 | 3.285 | 0.095 |
| Operating Income
| -3.943 | -5.461 | -11.041 | -1.324 | -1.162 | -1.578 | -1.325 | -2.047 | -3.385 | -4.539 | -0.068 | -2.696 | -3.912 | -4.568 | -2.642 | -3.56 | -0.095 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -1.268 | -47.332 | -17.725 | -51.183 | -169.24 | 0 | -18.87 | -6.287 | -45.508 | -39.622 | -36.718 | -7.317 | 0 |
| Total Other Income Expenses Net
| -0.451 | -0.02 | -0.936 | -4.496 | 0.48 | 1.18 | -1.393 | 0.55 | -0.151 | 1.021 | -4.678 | -0.2 | -0.2 | 0.544 | -2.306 | 0.128 | 0 |
| Income Before Tax
| -4.393 | -5.481 | -11.977 | -5.82 | -0.682 | -0.397 | -2.718 | -1.498 | -3.536 | -4.746 | -0.238 | -2.896 | -4.024 | -4.948 | -2.514 | -3.657 | -0.095 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -0.744 | -11.918 | -36.36 | -37.443 | -176.801 | 0 | -66.068 | -6.754 | -46.807 | -42.92 | -34.941 | -7.516 | 0 |
| Income Tax Expense
| -0.004 | 0.594 | 0.789 | -0.467 | 1.614 | 0 | 0 | 0 | 0 | 0.16 | 0.17 | 0 | 0.112 | 0 | 0.002 | 0.001 | 0 |
| Net Income
| -4.393 | -6.075 | -12.766 | -5.353 | -2.296 | -0.397 | -2.718 | -1.498 | -3.536 | -4.746 | -0.238 | -2.896 | -4.024 | -4.948 | -2.516 | -3.658 | -0.095 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -2.505 | -11.918 | -36.36 | -37.443 | -176.801 | 0 | -66.068 | -6.754 | -46.807 | -42.923 | -34.963 | -7.518 | 0 |
| EPS
| -1.24 | -3.45 | -16.13 | -19.57 | -44.16 | -7.97 | -58.25 | -52.67 | -212.02 | -3,052.41 | -203.04 | -2,436.01 | -3,846.97 | -4,628.91 | -2,201.14 | -2,935.69 | -75.92 |
| EPS Diluted
| -1.24 | -3.45 | -16.13 | -19.57 | -44.16 | -7.97 | -58.25 | -52.67 | -212.02 | -3,052.41 | -203.04 | -2,436.01 | -3,846.97 | -4,628.91 | -2,201.14 | -2,935.69 | -75.92 |
| EBITDA
| -3.943 | -5.407 | -11.933 | -5.33 | -0.093 | -1.578 | -1.302 | -1.976 | -3.301 | -0.481 | -4.539 | -1.9 | -2.696 | -2.674 | -4.568 | -2.441 | -0.095 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -0.102 | -47.326 | -17.416 | -49.401 | -165.027 | 0 | -1,258.041 | -4.431 | -31.363 | -23.194 | -63.479 | -5.017 | 0 |